Methods of treating or preventing neuropathic pain
AssigneeToray Industreis, Inc.
InventorsNaoki Izumimoto, Hidenori Mochizuki
Life of this patent
Estimating the term…
Abstract
A method treats or prevents neuropathic pain with a synergistically-enhanced analgesic effect at a dose at which a calcium channel α2δ ligand does not produce any side effects as well as which agent does not produce any new side effects on the central nervous system. The therapeutic agent or a prophylactic agent used in the method includes as effective ingredients a cyclohexane derivative or a pharmaceutically acceptable salt thereof or a prodrug thereof, and a calcium channel α2δ ligand.
Claims8
A method of treating or preventing neuropathic pain comprising separately administering a therapeutically or prophylactically effective amount of a cyclohexane derivative represented by Formula (I) below:
- wherein
- A is a substituent represented by Formula (IIa) or (IIb):
- R1 and R2 are each independently a hydrogen atom, a chlorine atom, a C1-C3 haloalkyl group, a C1-C4 alkyl group or a C1-C4 alkoxy group;
- R3 is a hydrogen atom or a chlorine atom;
- R4 is a fluorine atom, a hydroxymethyl group or a hydroxyl group;
- R5 and R6 are each independently a hydrogen atom, a fluorine atom, a C1-C3 haloalkyl group, a carboxyl group, a methoxycarbonyl group, an ethoxycarbonyl group, a C1-C4 alkoxy group, a hydroxyl group or a C2-C5 alkylcarbonyloxy group, or optionally together form an oxo group;
- R7 and R8 are each independently a hydrogen atom or a fluorine atom;
- Y is an oxygen atom or a sulfur atom;
- and
- Z is a nitrogen atom or a methine group or a pharmaceutically acceptable salt thereof or a prodrug thereof, and a calcium channel α2δ ligand.
Dependencies are inferred from the claim text.